Hypertension and Subclinical Vascular Damage After Allogeneic Hematopoietic Stem Cell Transplantation
Open Access
- 22 September 2026
- journal article
- Published by Elsevier in JACC: Advances
- Vol. 5 (11) , 103314
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Predictors of kidney complications and analysis of hypertension in children with allogeneic hematopoietic stem cell transplantationPediatric Nephrology, 2022
- Higher Peak Tacrolimus Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation Increase the Risk of Endothelial Cell Damage ComplicationsTransplantation and Cellular Therapy, 2018
- Ambulatory Blood Pressure and Endothelial Dysfunction in Hematopoietic Cell Transplantation RecipientsTransplantation and Cellular Therapy, 2018
- National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group ReportTransplantation and Cellular Therapy, 2017
- Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell TransplantationTransplantation and Cellular Therapy, 2016
- Treatment of Dyslipidemia in Allogeneic Hematopoietic Stem Cell Transplant PatientsTransplantation and Cellular Therapy, 2015
- Platelet activation and inflammatory response in patients with non-dipper hypertensionAtherosclerosis, 2010
- Umbilical Cord Blood Transplantation2008
- Vascular endothelium as ‘novel’ target of graft-versus-host diseaseBest Practice & Research Clinical Haematology, 2008
- Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic HypertensionJAMA, 1999